University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program
德克萨斯大学西南分校 - 促进住院医师研究 (UT-StARR) 计划
基本信息
- 批准号:10318221
- 负责人:
- 金额:$ 33.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAffectAsian IndianBiomedical ResearchBlack raceBloodBronchopulmonary DysplasiaCardiovascular DiseasesCessation of lifeChildhoodChronic DiseaseClinicalClinical ResearchCommunitiesConceptionsCongenital Heart DefectsCystic FibrosisDetectionDevelopmentDiagnosticDiseaseDoctor of MedicineEnsureEnvironmentEquilibriumEvaluationFacultyFoundationsFundingFutureHawaiianHealthHeartHeart DiseasesHemophilia AHispanicHospitalizationHospitalsHumanIndividualInstitutionInternal MedicineInterventionInvestigationLaboratoriesLongevityLungLung diseasesMaintenanceMedical StudentsMentorsMinorityMonitorPatient RecruitmentsPatientsPediatricsPhysiciansPopulationPopulation HeterogeneityPopulation ResearchPreventionRaceResearchResearch PersonnelResearch PriorityResearch TrainingResidenciesRiskScientistTeaching HospitalsTexasTrainingTraining ProgramsTranslational ResearchTreatment outcomeUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWomanWorkbasecareerdesigndisabilityexperiencefaculty mentorhealth disparityhuman diseaseimprovedinnovationinterestmedical schoolsmembermultidisciplinarynext generationpatient populationpersonalized medicinepopulation healthprogramsrecruitskillsstrength training
项目摘要
Project Abstract
Despite decades of research in the understanding and treatment of diseases of the heart and lung,
cardiovascular and pulmonary diseases remain the leading causes of hospitalization, disability, and death in the
U.S. Notably, growing numbers of patients with childhood-onset chronic illnesses, such as congenital heart
defects, cystic fibrosis, bronchopulmonary dysplasia, and hemophilia, are surviving into adulthood, making it
imperative to conduct research encompassing the lifespan. Against this background of critical research needs,
there is a strikingly growing shortage of M.D.-scientists, such that the proportion of M.D.s that remain primarily
in research careers has decreased by 3-fold in the last 3 decades, despite the climbing number of total physicians
in practice. The pipeline of M.D.-scientist development is also at risk: fewer medical students express interest in
a research career, and fewer graduates apply for NIH funding. Importantly, relative to the overall physician
workforce, women and minorities are disproportionately underrepresented in the proportion of M.D.-scientists.
These challenges require the implementation of innovative recruitment and training strategies to feed the M.D.-
scientist pipeline and ensure that women and minorities are well-represented. To help fill these critical gaps, we
will establish the University of Texas Southwestern (UTSW) - Stimulating Access to Research in
Residency (UT-StARR) training program to recruit and train a diverse group of Internal Medicine and Pediatrics
residents that will become the next generation of M.D.-scientists conducting laboratory-based, translational,
clinical, and population health research to detect, treat, and prognosticate diseases affecting the heart, lungs,
and blood of diverse populations throughout the lifespan. Our institution will provide an ideal environment with a
multidisciplinary cadre of funded research; robust didactic training program; and diverse patient population. We
hypothesize that the 3 axes of diversity at UTSW - M.D. trainees, mentors, and patient community - afford the
unique opportunity to address unmet needs in M.D. research training, personalized medicine, and population
health. The following Aims organize our approach: Aim 1. To provide broad-based comprehensive mentored
research training for a group of diverse Internal Medicine and Pediatric resident-investigators in the conception,
design, and implementation of laboratory-based, translational, clinical, and population research in diseases
affecting the heart, lungs and blood, encompassing detection, prevention, treatment, and outcomes to improve
the health of individuals and populations throughout the human lifespan; Aim 2. To provide the essential research
training and mentoring platform needed to build a strong foundation allowing successful transition of residents
to independent M.D.-scientists conducting biomedical research in the heart, lung, and blood fields; Aim 3. To
enhance the participation and persistence of M.D.s from underrepresented groups in research by implementation
and maintenance of institutional mentored residency training programs involving diverse residents, mentors, and
patients through evaluation and monitoring the progress of UT-StARR and other institutional training programs.
项目摘要
尽管在了解和治疗心脏和肺部疾病方面进行了数十年的研究,
心血管和肺部疾病仍然是住院、残疾和死亡的主要原因
值得注意的是,美国患有先天性心脏病等儿童期慢性疾病的患者数量不断增加
缺陷、囊性纤维化、支气管肺发育不良和血友病持续到成年,使其
开展涵盖生命周期的研究势在必行。在这种关键研究需求的背景下,
医学博士科学家的短缺日益严重,因此医学博士的比例仍然主要
尽管医生总数不断攀升,但在过去 30 年里,研究职业的数量却减少了 3 倍
在实践中。医学博士科学家的发展渠道也面临风险:表达兴趣的医学生越来越少
从事研究工作,申请 NIH 资助的毕业生越来越少。重要的是,相对于整体医生
劳动力、妇女和少数族裔在医学博士科学家的比例中所占比例过低。
这些挑战需要实施创新的招聘和培训策略来满足医学博士的需求
科学家管道并确保妇女和少数族裔的代表性。为了帮助填补这些关键空白,我们
将建立德克萨斯大学西南分校 (UTSW) - 促进获得以下领域的研究机会
住院医师 (UT-StARR) 培训计划,旨在招募和培训多元化的内科和儿科团队
居民将成为下一代医学博士科学家,进行基于实验室的、转化的、
临床和人口健康研究,用于检测、治疗和预测影响心脏、肺、
以及不同人群整个生命周期的血液。我们的机构将提供一个理想的环境
受资助研究的多学科骨干;健全的教学培训计划;和多样化的患者群体。我们
假设 UTSW 的 3 个多元化轴——医学博士实习生、导师和患者社区——提供了
解决医学博士研究培训、个性化医疗和人口方面未满足需求的独特机会
健康。我们的方法遵循以下目标: 目标 1. 提供基础广泛的全面指导
为一群不同的内科和儿科住院医师进行受孕方面的研究培训,
设计和实施基于实验室、转化、临床和人群的疾病研究
影响心脏、肺和血液,包括检测、预防、治疗和改善结果
整个人类生命周期中个人和人群的健康;目标 2. 提供必要的研究
需要培训和指导平台来建立坚实的基础,使居民能够成功过渡
在心脏、肺和血液领域进行生物医学研究的独立医学博士科学家;目标 3. 至
通过实施提高代表性不足群体的医学博士对研究的参与和坚持
和维护机构指导的住院医师培训计划,涉及不同的住院医师、导师和
通过评估和监测 UT-StARR 和其他机构培训计划的进展来帮助患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Hedayati其他文献
Susan Hedayati的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Hedayati', 18)}}的其他基金
Blood Biomarkers Associated with Adverse Outcomes in Heart Failure
与心力衰竭不良后果相关的血液生物标志物
- 批准号:
10650694 - 财政年份:2023
- 资助金额:
$ 33.47万 - 项目类别:
Mechanisms for Behavior Change and Maintenance of Treatment for CKD Comorbid Depression
CKD 共病抑郁症的行为改变和维持治疗机制
- 批准号:
10667222 - 财政年份:2022
- 资助金额:
$ 33.47万 - 项目类别:
Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)
CKD 共病抑郁症的新疗法组合 (CONCORD)
- 批准号:
10640205 - 财政年份:2020
- 资助金额:
$ 33.47万 - 项目类别:
Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)
CKD 共病抑郁症的新疗法组合 (CONCORD)
- 批准号:
10404490 - 财政年份:2020
- 资助金额:
$ 33.47万 - 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
- 批准号:
8792383 - 财政年份:2011
- 资助金额:
$ 33.47万 - 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
- 批准号:
8042121 - 财政年份:2011
- 资助金额:
$ 33.47万 - 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
- 批准号:
8607181 - 财政年份:2011
- 资助金额:
$ 33.47万 - 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
- 批准号:
8212573 - 财政年份:2011
- 资助金额:
$ 33.47万 - 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
- 批准号:
8423402 - 财政年份:2011
- 资助金额:
$ 33.47万 - 项目类别:
Randomized trial of sertraline treatment of depression in Chronic Kidney Disease
舍曲林治疗慢性肾脏病抑郁症的随机试验
- 批准号:
7787841 - 财政年份:2009
- 资助金额:
$ 33.47万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 33.47万 - 项目类别: